NCT07251894
Pilot Study Exploring the Feasibility, Acceptability, and Impact of Medically Tailored Meals on Post-Discharge Recovery in Patients With Heart Failure
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesUniversity of PennsylvaniaInvestigator-initiated
~85 participants
Updated 2026-04-08 on ClinicalTrials.gov
What's tested:Medically Tailored Meals
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of the MTM intervention
Measured over From enrollment to the end of the intervention at 4 weeks for Pilot 1
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age ≥ 18 years old
Have a primary diagnosis of health failure based on ICD code I50\* with active hospitalization at time of enrollment
Must be insured by Medicaid or Medicare or dual eligible
Ability to read and speak English
Ability to provide informed consent
Exclusion
Are on hospice care or reside in an acute or skilled nursing facility
Are undergoing evaluation for advanced HF treatments including heart transplant or ventricular assist devices
Are unable to complete data collection due to cognitive decline or disability (based on the electronic health record or referring provider assessment)
What this trial measures
- Feasibility of the MTM interventionFrom enrollment to the end of the intervention at 4 weeks for Pilot 1
The % of meals successfully delivered to the patient, where a 75% rate of successful delivery indicates feasibility.
- Acceptability of the MTM intervention as measured by the Net Promoter ScoreAt the end of the intervention at 4 weeks for Pilot 1.
Will evaluate the acceptability of the intervention among patients through the Net Promoter Score (scale of 0 to 10; 9-10 being promoters, 7-8 being passives, and 0-6 being detractors)